"Vimentin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.
| Descriptor ID |
D014746
|
| MeSH Number(s) |
D05.750.078.593.900 D12.776.220.475.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vimentin".
Below are MeSH descriptors whose meaning is more specific than "Vimentin".
This graph shows the total number of publications written about "Vimentin" by people in this website by year, and whether "Vimentin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vimentin" by people in Profiles.
-
Anti-vimentin antibodies are associated with higher severity of Sj?gren's disease. Clin Immunol. 2023 02; 247:109243.
-
Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2020 05 11; 61(5):22.
-
Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation. Exp Mol Pathol. 2018 12; 105(3):243-251.
-
Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGF? pathway. Cancer Prev Res (Phila). 2014 Oct; 7(10):1045-55.
-
Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy". PLoS One. 2013; 8(5):e64181.
-
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6700-5.
-
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma. Int J Clin Exp Pathol. 2011; 4(7):651-60.
-
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res. 2011 Mar 15; 71(6):2328-38.
-
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009 Dec; 133(3):353-63.
-
The ependymal route for insulin-like growth factor-1 gene therapy in the brain. Neuroscience. 2009 Sep 29; 163(1):442-7.